This inventor holds 1 USPTO granted patent and 1 EPO patent. Top assignee: Advenchen Pharmaceuticals, LLC. Active years: 2020.
Company Filing History:
Years Active: 2020
Title: Yan Changren: Innovator in Pharmaceutical Compounds
Introduction
Yan Changren is a notable inventor based in Moorpark, CA (US). He has made significant contributions to the field of pharmaceuticals, particularly in the development of compounds that target critical pathways in cancer treatment.
Latest Patents
Yan Changren holds a patent for "Fused quinoline compounds as PI3K/mTOR inhibitors." This invention relates to compounds that can be used in the treatment of diseases associated with cancers linked to protein kinases. The patent outlines processes for the preparation of these compounds, their pharmaceutical compositions, and their application as medicaments to inhibit mTor and PI3K, thereby reducing effects in warm-blooded animals, including humans. He has 1 patent to his name.
Career Highlights
Yan is currently employed at Advenchen Pharmaceuticals, LLC, where he continues to innovate in the pharmaceutical sector. His work focuses on developing new therapeutic options for cancer treatment, leveraging his expertise in medicinal chemistry.
Collaborations
Some of his notable coworkers include Paul Chen Guoqing and Monica Chen, who contribute to the collaborative efforts at Advenchen Pharmaceuticals.
Conclusion
Yan Changren's work in developing PI3K/mTOR inhibitors represents a significant advancement in cancer treatment. His innovative approach and dedication to pharmaceutical research continue to pave the way for new therapeutic solutions.